Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Baird Downgrades Acuity Brands to Neutral, Lowers Price Target to $190

Baird Downgrades Acuity Brands to Neutral, Lowers Price Target to $190

Baird analyst Timothy Wojs downgrades Acuity Brands (NYSE:AYI) from Outperform to Neutral and lowers the price target from $200 to $190.

byBenzinga Newsdesk

December 16, 2022

1 minute read

Baird analyst Timothy Wojs downgrades Acuity Brands (NYSE:AYI) from Outperform to Neutral and lowers the price target from $200 to $190.

Musk’s SpaceX Boosts Satellite Fleet In Low-Earth Orbit While Amazon’s Prototype Launch Faces Delay

By Anan Ashraf

June 5, 2:35 AM

Elon Musk‘s SpaceX launched 22 Starlink satellites to low-Earth orbit (LEO) from Florida on Sunday aboard a Falcon…

AMZN

AbbVie Analysts Increase Their Forecasts After Upbeat Earnings

By Lisa Levin

October 30, 2:55 PM

AbbVie Inc (NYSE: ABBV) reported better-than-expected earnings for its third quarter and raised its profit outlook on Friday.

ABBV

Why Novavax Stock Fell Today

By Ryan Gustafson

October 4, 7:22 PM

Novavax, Inc. (NASDAQ: NVAX) shares are trading lower Wednesday amid a pullback in the stock, which gained Tuesday after the FDA granted Emergency Use Authorization for the company's updated protein-based COVID-19 vaccine for

BNTX

Analyst Ratings

10 Analysts Have This to Say About MetLife

By Benzinga Insights

June 2, 9:00 AM

Analysts have provided the following ratings for MetLife (NYSE:MET) within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat…

MET

Baird Downgrades Acuity Brands to Neutral, Lowers Price Target to $190

Related Posts

Musk’s SpaceX Boosts Satellite Fleet In Low-Earth Orbit While Amazon’s Prototype Launch Faces Delay

AbbVie Analysts Increase Their Forecasts After Upbeat Earnings

Why Novavax Stock Fell Today

10 Analysts Have This to Say About MetLife